Ionis Pharmaceuticals, Inc. (IONS) Social Stream
Ionis Pharmaceuticals Inc (IONS) Price Targets From Analysts
Use the tables below to see what analysts covering Ionis Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
IONS's average price target has moved down $13.02 over the prior 166 days.
Over the past 50 weeks, IONS's average upside potential has been 38.9%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
IONS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 13 months, IONS's average broker recommendation rating improved by 0.19.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Ionis Pharmaceuticals Inc's variance in analysts' estimates is lower than -466.87% of them.
- In terms of how Ionis Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 533.22% of that group.
- IONS has a higher upside potential (average analyst target price relative to current price) than 110.51% of Pharmaceutical Products stocks.
- In the context of stocks in the large market cap category, Ionis Pharmaceuticals Inc's average analyst price target is higher than 143.57% of them.
Is IONS a Buy, Hold or Sell? See the POWR Ratings now!